B6;129P2-Hspa13tm1Yah Apptm1Yah/++/Orl

Status

Available to order

EMMA IDEM:02387
Citation informationRRID:IMSR_EM:02387 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129P2-Hspa13tm1Yah Apptm1Yah/++/Orl
Alternative nameSA218 cis(Stch-App)
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolApptm1Yah, Hspa13tm1Yah
Gene/Transgene symbolApp, Hspa13

Information from provider

ProviderYann HERAULT
Provider affiliationTAAM-CDTA UPS44, CNRS-TAAM – Typing and Archiving of Animal Models
Genetic informationInsertion by homologous recombination in ES cells using two targeting vectors derived from the MICER resource, one containing a loxP site at the Stch (Hspa13) locus and a second vector containing a loxP site at the App locus, in a cis configuration. The mouse line was established from the SA218 ES cell clone.
Phenotypic informationNo visible phenotype.
Breeding historyLoxP insertions at loci Stch (Hspa13) and App were generated in a cis configuration in 129P2 ES cells. Cells were injected in C57BL/6J blastocysts, backcrossed on C57BL/6J and then intercrossed. F2, N4, G6 at present.
ReferencesNone available

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • preweaning lethality, incomplete penetrance / IMPC
  • increased cornea thickness / IMPC
  • decreased total retina thickness / IMPC
  • short tibia / IMPC
  • increased circulating calcium level / IMPC
  • increased blood urea nitrogen level / IMPC
  • decreased grip strength / IMPC
MGI phenotypes (allele matching)
  • no phenotypic analysis / MGI
MGI phenotypes (gene matching)
  • amyloidosis / MGI
  • muscle degeneration / MGI
  • decreased corpus callosum size / MGI
  • abnormal telencephalon morphology / MGI
  • decreased body weight / MGI
  • increased anxiety-related response / MGI
  • abnormal locomotor behavior / MGI
  • hyperactivity / MGI
  • hypoactivity / MGI
  • decreased exploration in new environment / MGI
  • abnormal cued conditioning behavior / MGI
  • abnormal spatial learning / MGI
  • reduced long term potentiation / MGI
  • impaired swimming / MGI
  • intracerebral hemorrhage / MGI
  • abnormal learning/memory/conditioning / MGI
  • abnormal fear/anxiety-related behavior / MGI
  • abnormal motor capabilities/coordination/movement / MGI
  • premature death / MGI
  • abnormal brain morphology / MGI
  • no abnormal phenotype detected / MGI
  • decreased brain weight / MGI
  • gliosis / MGI
  • absent corpus callosum / MGI
  • abnormal brain commissure morphology / MGI
  • abnormal long term potentiation / MGI
  • abnormal emotion/affect behavior / MGI
  • increased thigmotaxis / MGI
  • abnormal active avoidance behavior / MGI
  • abnormal long term object recognition memory / MGI
  • abnormal neuron morphology / MGI
  • no phenotypic analysis / MGI
  • abnormal locomotor activation / MGI
  • amyloid beta deposits / MGI
  • astrocytosis / MGI
  • nervous system phenotype / MGI
  • impaired passive avoidance behavior / MGI
  • myositis / MGI
  • homeostasis/metabolism phenotype / MGI
  • growth/size/body region phenotype / MGI
  • behavior/neurological phenotype / MGI
  • abnormal cell physiology / MGI
  • decreased hippocampal commissure size / MGI
  • decreased anterior commissure size / MGI
  • abnormal spatial reference memory / MGI
  • hematoma / MGI
  • microgliosis / MGI
  • increased variability of skeletal muscle fiber size / MGI
  • centrally nucleated skeletal muscle fibers / MGI
  • abnormal synapse morphology / MGI
  • decreased grip strength / MGI
  • altered susceptibility to induced thrombosis / MGI
  • abnormal circadian behavior / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).